Marbofloxacin Suppresses Breast Cancer Growth Through Oxidative Stress and Metabolic Reprogramming with Predicted HSP90AA1–EGFR Network Modulation

Mervenur Yavuz, Firli R. P. Dewi, İlknur Keskin, Turan Demircan

Open source

DOI
10.3390/ph19091327
Published
2026-08-22
Container
Pharmaceuticals
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph19091327,
  title = {Marbofloxacin Suppresses Breast Cancer Growth Through Oxidative Stress and Metabolic Reprogramming with Predicted HSP90AA1–EGFR Network Modulation},
  author = {Mervenur Yavuz and Firli R. P. Dewi and İlknur Keskin and Turan Demircan},
  year = {2026},
  journal = {Pharmaceuticals},
  doi = {10.3390/ph19091327},
  url = {https://doi.org/10.3390/ph19091327}
}

RIS

TY  - JOUR
TI  - Marbofloxacin Suppresses Breast Cancer Growth Through Oxidative Stress and Metabolic Reprogramming with Predicted HSP90AA1–EGFR Network Modulation
AU  - Mervenur Yavuz
AU  - Firli R. P. Dewi
AU  - İlknur Keskin
AU  - Turan Demircan
PY  - 2026
JO  - Pharmaceuticals
DO  - 10.3390/ph19091327
UR  - https://doi.org/10.3390/ph19091327
ER  - 

APA

Yavuz, M., Dewi, F. R. P., Keskin, İ., & Demircan, T. (2026). Marbofloxacin Suppresses Breast Cancer Growth Through Oxidative Stress and Metabolic Reprogramming with Predicted HSP90AA1–EGFR Network Modulation. Pharmaceuticals. https://doi.org/10.3390/ph19091327

Source records